Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
FDA Approves Dupixent for Bullous Pemphigoid
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.The approval is based on res
Mild Obstructive Sleep Apnea More Common in Female Athletes Than Expected
can significantly improve quality of life and, depending on disease severity, potentially reduce long-term cardiovascular risk, Rim said in a statement.Press Re
U.S. Drug Overdose Deaths Started Declining in 2023
U.S. drug overdose deaths (DODs) started declining in 2023, with a faster decline for opioid-related versus stimulant-related DOD rates, according to a study pu
USPSTF: Screen Women of Reproductive Age for Intimate Partner Violence
The U.S. Preventive Services Task Force (USPSTF) recommends screening women of reproductive age for intimate partner violence (IPV). These findings form the bas
Cystic Fibrosis: Symptoms, Treatments, Causes & More
TUESDAY, June 24, 2025 Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that d
Blood Test Might Predict MS Relapse
TUESDAY, June 24, 2025 A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.Blood level
Studies Address Muscle Loss Caused By GLP-1 Drugs
TUESDAY, June 24, 2025 GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat. Expert
Weighted Vests Don't Protect Bone Health In Dieting Seniors, Trial Says
TUESDAY, June 24, 2025 Weighted vests have been touted as a potential means of warding off osteoporosis while losing weight. The idea is that the extra weight w
VR Might Aid Stroke Recovery
TUESDAY, June 24, 2025 Virtual reality (VR) training might help stroke survivors regain their arm movement, a new evidence review says. The results indicate tha
Results From Amgen's Phase 2 Obesity Study of Monthly MariTide Presented at the American Diabetes Association 85th Scientific Sessions
Amgen (NASDAQ AMGN) today announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), a long-acting, peptid
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions